We advocate for a strengthened U.S. response to antimicrobial resistance including regulatory and legislative efforts to spur development of antibiotics and related diagnostic tests; enhanced coordination and leadership, surveillance, prevention and control, and research efforts; and the promotion of antibiotics’ appropriate use in humans and in agriculture.
We are advancing principles to address the unacceptably low rates of immunization coverage among U.S. adults and adolescents.
To protect patients, healthcare personnel (HCP), and the general population against influenza, we are advancing principles to promote the mandatory immunization of all HCP.
We promote the reform of federal regulations that have created impediments to the conduct of critical health research, often as a result of unintended consequences or regulations that have not kept pace with the changing research landscape.
A long-standing legislative priority, IDSA seeks Medicare coverage for patients who would benefit from taking antimicrobial infusion therapy in their homes.